Medtronic plc Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Medtronic plc (MDT) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$89.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-03
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-07-31 was -$89.00M, a 232.84% decline year-over-year.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-07-25 was $67.00M, a 116.13% increase year-over-year.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-07-26 was $31.00M.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-07-28 was -$39.00M.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2026 was $85.00M, a 54.79% decline from fiscal 2025.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $188.00M.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$230.00M, a 194.65% decline from fiscal 2023.
- Medtronic plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $243.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$89.00M 10-Q · filed 2026-09-03 | |||
| 2026-04-24 | $85.00M 10-K · filed 2026-06-18 | |||
| 2026-01-23 | $52.00M 10-Q · filed 2026-02-24 | |||
| 2025-10-24 | $28.00M 10-Q · filed 2025-11-25 | |||
| 2025-07-25 | $67.00M 10-Q · filed 2026-09-03 | |||
| 2025-04-25 | $188.00M 10-K · filed 2026-06-18 | |||
| 2025-01-24 | -$95.00M 10-Q · filed 2026-02-24 | |||
| 2024-10-25 | $35.00M 10-Q · filed 2025-11-25 | |||
| 2024-07-26 | $31.00M 10-Q · filed 2025-08-26 | |||
| 2024-04-26 | -$230.00M 10-K · filed 2026-06-18 | |||
| 2024-01-26 | -$170.00M 10-Q · filed 2025-02-25 | |||
| 2023-10-27 | -$214.00M 10-Q · filed 2024-11-26 | |||
| 2023-07-28 | -$39.00M 10-Q · filed 2024-08-27 | |||
| 2023-04-28 | $243.00M 10-K · filed 2025-06-20 | |||
| 2023-01-27 | $317.00M 10-Q · filed 2024-02-27 | |||
| 2022-10-28 | -$223.00M 10-Q · filed 2023-11-30 | |||
| 2022-07-29 | -$122.00M 10-Q · filed 2023-08-31 | |||
| 2022-04-29 | -$231.00M 10-K · filed 2024-06-20 | |||
| 2022-01-28 | -$87.00M 10-Q · filed 2023-03-01 | |||
| 2021-10-29 | -$51.00M 10-Q · filed 2022-12-01 | |||
| 2021-07-30 | -$42.00M 10-Q · filed 2022-09-01 | |||
| 2021-04-30 | $215.00M 10-K · filed 2023-06-22 | |||
| 2021-01-29 | $234.00M 10-Q · filed 2022-03-03 | |||
| 2020-10-30 | $162.00M 10-Q · filed 2021-12-02 | |||
| 2020-07-31 | $114.00M 10-Q · filed 2021-09-02 | |||
| 2020-04-24 | -$86.00M 10-K · filed 2022-06-23 | |||
| 2020-01-24 | -$12.00M 10-Q · filed 2021-03-05 | |||
| 2019-10-25 | -$26.00M 10-Q · filed 2020-12-03 | |||
| 2019-07-26 | $2.00M 10-Q · filed 2020-09-03 | |||
| 2019-04-26 | -$78.00M 10-K · filed 2021-06-25 | |||
| 2019-01-25 | -$70.00M 10-Q · filed 2020-02-28 | |||
| 2018-10-26 | -$84.00M 10-Q · filed 2019-12-03 | |||
| 2018-04-27 | $114.00M 10-K · filed 2020-06-19 | |||
| 2017-04-28 | $65.00M 10-K · filed 2019-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |